Treatment of major depressive disorder using botulinum toxin a: A 24-week randomized, double-blind, placebo-controlled study

Michelle Magid, Jason S. Reichenberg, Poppy E. Poth, Henry T. Robertson, Amanda K. LaViolette, Tillmann H C Kruger, M. Axel Wollmer

Research output: Contribution to journalArticlepeer-review

107 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of major depressive disorder using botulinum toxin a: A 24-week randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences